LGALS3 and Alzheimer disease: In this case, Clec7a coverage per amyloid plaque was significantly greater in Gal3KO mice at both 3 and 6 months of age (Figures 5a,b), indicating that the Clec7a upregulation observed in vitro in the absence of Gal3 is maintained during AD pathology.